ZA977597B - Spirocyclic dopamine receptor subtype ligands - Google Patents
Spirocyclic dopamine receptor subtype ligandsInfo
- Publication number
- ZA977597B ZA977597B ZA977597A ZA977597A ZA977597B ZA 977597 B ZA977597 B ZA 977597B ZA 977597 A ZA977597 A ZA 977597A ZA 977597 A ZA977597 A ZA 977597A ZA 977597 B ZA977597 B ZA 977597B
- Authority
- ZA
- South Africa
- Prior art keywords
- spirocyclic
- dopamine receptor
- receptor subtype
- subtype ligands
- ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
- C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/112—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2479796P | 1996-08-26 | 1996-08-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA977597B true ZA977597B (en) | 1999-02-25 |
Family
ID=21822443
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA977597A ZA977597B (en) | 1996-08-26 | 1997-08-25 | Spirocyclic dopamine receptor subtype ligands |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6664258B1 (en) |
| EP (1) | EP0925291B1 (en) |
| JP (1) | JP3152941B2 (en) |
| AP (1) | AP9701075A0 (en) |
| AR (1) | AR013836A1 (en) |
| AT (1) | ATE311377T1 (en) |
| AU (1) | AU3632297A (en) |
| CA (1) | CA2264549C (en) |
| CO (1) | CO4560554A1 (en) |
| DE (1) | DE69734774D1 (en) |
| GT (1) | GT199700096A (en) |
| HN (1) | HN1997000117A (en) |
| HR (1) | HRP970455A2 (en) |
| ID (1) | ID18076A (en) |
| IL (1) | IL128050A0 (en) |
| IS (1) | IS4969A (en) |
| MA (1) | MA26437A1 (en) |
| PA (1) | PA8436501A1 (en) |
| PE (1) | PE108498A1 (en) |
| TN (1) | TNSN97143A1 (en) |
| WO (1) | WO1998008835A1 (en) |
| ZA (1) | ZA977597B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0953567A3 (en) * | 1998-04-29 | 2003-04-02 | Pfizer Products Inc. | Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity |
| WO2000017163A1 (en) * | 1998-09-22 | 2000-03-30 | Yamanouchi Pharmaceutical Co., Ltd. | Cyanophenyl derivatives |
| EP1177792A3 (en) * | 2000-07-27 | 2002-10-23 | Pfizer Products Inc. | Dopamine D4 Ligands for the treatment of novelty-seeking disorders |
| GB0328906D0 (en) | 2003-12-12 | 2004-01-14 | Syngenta Participations Ag | Chemical compounds |
| EP2780015B1 (en) | 2011-11-18 | 2017-01-04 | Heptares Therapeutics Limited | Muscarinic m1 receptor agonists |
| GB201617454D0 (en) * | 2016-10-14 | 2016-11-30 | Heptares Therapeutics Limited | Pharmaceutical compounds |
| GB201810239D0 (en) | 2018-06-22 | 2018-08-08 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
| GB201819960D0 (en) | 2018-12-07 | 2019-01-23 | Heptares Therapeutics Ltd | Pharmaceutical compounds |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE758919A (en) | 1969-11-15 | 1971-05-13 | Merck Patent Gmbh | SPIRO-COMPOUNDS |
| US4025558A (en) | 1974-04-12 | 1977-05-24 | The Upjohn Company | Organic compounds |
| US3932425A (en) | 1974-04-12 | 1976-01-13 | The Upjohn Company | Benzospiran derivatives |
| US4010201A (en) | 1974-04-12 | 1977-03-01 | The Upjohn Company | Organic compounds |
| DE2818329A1 (en) | 1978-04-26 | 1979-11-08 | Yoshitomi Pharmaceutical | Substd. spiro cyclohexane thioxanthene CNS depressants - prepd. from a spiro cyclohexanone thioxanthene |
| CA2091204C (en) | 1992-03-11 | 1997-04-08 | Ronald J. Mattson | Antiischemic-piperazinyl and piperidinyl-cyclohexanes |
| JPH08502508A (en) | 1992-10-23 | 1996-03-19 | メルク シヤープ エンド ドーム リミテツド | Dopamine receptor subtype ligand |
| GB9317631D0 (en) | 1993-08-25 | 1993-10-13 | Bxl Plastics Ltd | Multi-layered composite |
| US5403846A (en) * | 1993-11-22 | 1995-04-04 | Merck & Co., Inc. | Spirocycles |
| CA2189634A1 (en) | 1994-05-06 | 1995-11-16 | John J. Baldwin | Combinatorial dihydrobenzopyran library |
| GB9410031D0 (en) | 1994-05-19 | 1994-07-06 | Merck Sharp & Dohme | Therapeutic agents |
-
1997
- 1997-08-08 EP EP97932964A patent/EP0925291B1/en not_active Expired - Lifetime
- 1997-08-08 WO PCT/IB1997/000978 patent/WO1998008835A1/en active IP Right Grant
- 1997-08-08 AT AT97932964T patent/ATE311377T1/en not_active IP Right Cessation
- 1997-08-08 US US09/242,819 patent/US6664258B1/en not_active Expired - Fee Related
- 1997-08-08 JP JP51143198A patent/JP3152941B2/en not_active Expired - Fee Related
- 1997-08-08 CA CA002264549A patent/CA2264549C/en not_active Expired - Fee Related
- 1997-08-08 AU AU36322/97A patent/AU3632297A/en not_active Abandoned
- 1997-08-08 IL IL12805097A patent/IL128050A0/en unknown
- 1997-08-08 DE DE69734774T patent/DE69734774D1/en not_active Expired - Lifetime
- 1997-08-12 HN HN1997000117A patent/HN1997000117A/en unknown
- 1997-08-19 PE PE1997000731A patent/PE108498A1/en not_active Application Discontinuation
- 1997-08-21 AP APAP/P/1997/001075A patent/AP9701075A0/en unknown
- 1997-08-22 CO CO97048585A patent/CO4560554A1/en unknown
- 1997-08-22 PA PA19978436501A patent/PA8436501A1/en unknown
- 1997-08-22 HR HR60/024,797A patent/HRP970455A2/en not_active Application Discontinuation
- 1997-08-22 AR ARP970103835A patent/AR013836A1/en unknown
- 1997-08-25 MA MA24775A patent/MA26437A1/en unknown
- 1997-08-25 TN TNTNSN97143A patent/TNSN97143A1/en unknown
- 1997-08-25 ZA ZA977597A patent/ZA977597B/en unknown
- 1997-08-25 GT GT199700096A patent/GT199700096A/en unknown
- 1997-08-25 ID IDP972950A patent/ID18076A/en unknown
-
1999
- 1999-02-05 IS IS4969A patent/IS4969A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HN1997000117A (en) | 1997-12-26 |
| GT199700096A (en) | 1999-02-16 |
| PE108498A1 (en) | 1999-01-29 |
| PA8436501A1 (en) | 2000-05-24 |
| CA2264549C (en) | 2004-09-14 |
| CO4560554A1 (en) | 1998-02-10 |
| JP3152941B2 (en) | 2001-04-03 |
| CA2264549A1 (en) | 1998-03-05 |
| DE69734774D1 (en) | 2006-01-05 |
| ATE311377T1 (en) | 2005-12-15 |
| AU3632297A (en) | 1998-03-19 |
| MA26437A1 (en) | 2004-12-20 |
| IS4969A (en) | 1999-02-05 |
| HRP970455A2 (en) | 1998-08-31 |
| TNSN97143A1 (en) | 2005-03-15 |
| JP2000502360A (en) | 2000-02-29 |
| EP0925291B1 (en) | 2005-11-30 |
| EP0925291A1 (en) | 1999-06-30 |
| ID18076A (en) | 1998-02-26 |
| AP9701075A0 (en) | 1997-10-31 |
| WO1998008835A1 (en) | 1998-03-05 |
| US6664258B1 (en) | 2003-12-16 |
| AR013836A1 (en) | 2001-01-31 |
| IL128050A0 (en) | 1999-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9901436A3 (en) | N-aminoalkylfluorenecarboxamides as dopamine receptor subtype ligands | |
| AU4057097A (en) | Fused indolecarboxamides: dopamine receptor subtype specific ligands | |
| HUP0104666A3 (en) | Thyroid receptor ligands | |
| HU9601529D0 (en) | Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists | |
| HU9603525D0 (en) | Vironectin receptor antagonists | |
| AU8096798A (en) | Dopamine d4 receptor ligands | |
| AU2738297A (en) | Tricyclic aminoalkylcarboxamides; novel dopamine d3 receptor subtype specific ligands | |
| HRP970301B1 (en) | Benzoxazinone dopamine d4 receptor antagonists | |
| HK1038749A1 (en) | 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands | |
| EP0993829A4 (en) | Transdermal preparation containing serotonin receptor antagonist | |
| ZA977597B (en) | Spirocyclic dopamine receptor subtype ligands | |
| GB9704376D0 (en) | Tetrahydropyridine derivatives as dopamine receptor subtype ligands | |
| SG70655A1 (en) | New spirocyclic compounds | |
| AU1286399A (en) | 3-aminoalkylamino- 2h-1,4-benzoxazines and 3-aminoalkylamino- 2h-1,4-benzothiazines: dopamine receptor subtype specific ligands | |
| AU2459597A (en) | N-aminoalkyl-2-anthraquinonecarboxamides; new dopamine receptor subtype specific ligands | |
| AU2335797A (en) | Novel n-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands | |
| AU4867496A (en) | Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands | |
| GB9703382D0 (en) | Tetrahydropyridine derivatives as dopamine receptor subtype ligands | |
| AU4420296A (en) | Aminomethyl aryl compounds; dopamine receptor subtype selective ligands | |
| AU4337599A (en) | Substituted 1-aryl-3-benzylaminopyrrolidine: dopamine receptor subtype specific ligands | |
| EP0914610A4 (en) | Screen for ecdysone receptor ligands | |
| HK1038887A1 (en) | C3a receptor ligands | |
| AU4600296A (en) | Opiate receptor ligands | |
| IL128629A0 (en) | Troponyl piperazines as selective dopamine D4 receptor ligands | |
| GB9803062D0 (en) | Estrogen receptor ligands |